Clinical Trials

Showing trials with last updates posted in 2021.

NCT01593267 | UNKNOWN | NA
500 participants

Barrow Ruptured Aneurysm Trial

Study Type:
INTERVENTIONAL
Last Updated:
2021-09-21
Start Date:
2002-11-30
Completion:
2019-10-25
Conditions
  • Ruptured Cerebral Aneurysm
  • Subarachnoid Hemorrhage (SAH)
Interventions
  • PROCEDURE
No Results Yet
NCT00900120 | WITHDRAWN
0 participants

Collecting and Storing Blood Samples From Patients With Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2021-09-21
Start Date:
2004-03-31
Completion:
2011-05-31
Conditions
  • Brain and Central Nervous System Tumors
  • Chronic Myeloproliferative Disorders
  • Leukemia
  • Lymphoma
  • Lymphoproliferative Disorder
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Nonmalignant Neoplasm
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Unspecified Childhood Solid Tumor, Protocol Specific
No Results Yet
NCT05050630 | UNKNOWN | PHASE2
73 participants

Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

Study Type:
INTERVENTIONAL
Last Updated:
2021-09-20
Start Date:
2021-08-01
Completion:
2022-07-30
Conditions
  • Age Range ≥16 Years, Gender Unlimited
  • Histopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma
  • Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed
  • At Least One Positive Lesion According to the 2014 Lugano Criteria for Hodgkin's and Non-Hodgkin's Lymphoma
  • ECOG Physical Status Score is 0-3
  • The Researchers Judged That Life Expectancy Was at Least Three Months
  • Understand and Voluntarily Sign Written Informed Consent
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page